Bright Minds Biosciences (DRUG) Gross Profit: 2019-2021
Historic Gross Profit for Bright Minds Biosciences (DRUG) over the last 3 years, with Sep 2021 value amounting to -$312,240.
- Bright Minds Biosciences' Gross Profit was N/A to -$124,390 in Q3 2021 from the same period last year, while for Sep 2021 it was -$316,831, marking a year-over-year change of. This contributed to the annual value of -$312,240 for FY2021, which is 12.63% up from last year.
- As of FY2021, Bright Minds Biosciences' Gross Profit stood at -$312,240, which was up 12.63% from -$357,388 recorded in FY2020.
- In the past 5 years, Bright Minds Biosciences' Gross Profit registered a high of $59,638 during FY2019, and its lowest value of -$357,388 during FY2020.
- For the 3-year period, Bright Minds Biosciences' Gross Profit averaged around -$203,330, with its median value being -$312,240 (2021).
- In the last 5 years, Bright Minds Biosciences' Gross Profit plummeted by 699.26% in 2020 and then climbed by 12.63% in 2021.
- Yearly analysis of 3 years shows Bright Minds Biosciences' Gross Profit stood at $59,638 in 2019, then slumped by 699.26% to -$357,388 in 2020, then grew by 12.63% to -$312,240 in 2021.